Literature DB >> 19281786

Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum.

Karina J Vargas1, José M Sarmiento, Pamela Ehrenfeld, Carolina C Añazco, Carolina I Villanueva, Pamela L Carmona, Marianne Brenet, Javier Navarro, Werner Müller-Esterl, Carlos B González.   

Abstract

The V(2) vasopressin receptor gene contains an alternative splice site in exon-3, which leads to the generation of two splice variants (V(2a) and V(2b)) first identified in the kidney. The open reading frame of the alternatively spliced V(2b) transcript encodes a truncated receptor, showing the same amino acid sequence as the canonical V(2a) receptor up to the sixth transmembrane segment, but displaying a distinct sequence to the corresponding seventh transmembrane segment and C-terminal domain relative to the V(2a) receptor. Here, we demonstrate the postnatal expression of V(2a) and V(2b) variants in the rat cerebellum. Most importantly, we showed by in situ hybridization and immunocytochemistry that both V(2) splice variants were preferentially expressed in Purkinje cells, from early to late postnatal development. In addition, both variants were transiently expressed in the neuroblastic external granule cells and Bergmann fibers. These results indicate that the cellular distributions of both splice variants are developmentally regulated, and suggest that the transient expression of the V(2) receptor is involved in the mechanisms of cerebellar cytodifferentiation by AVP. Finally, transfected CHO-K1 expressing similar amounts of both V(2) splice variants, as that found in the cerebellum, showed a significant reduction in the surface expression of V(2a) receptors, suggesting that the differential expression of the V(2) splice variants regulates the vasopressin signaling in the cerebellum.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281786      PMCID: PMC2846433          DOI: 10.1016/j.diff.2008.11.002

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  59 in total

1.  Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression.

Authors:  C L Thurston; I G Campbell; E S Culhane; E Carstens; L R Watkins
Journal:  Peptides       Date:  1992 Jan-Feb       Impact factor: 3.750

Review 2.  Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain.

Authors:  E Tribollet; M Goumaz; M Raggenbass; J J Dreifuss
Journal:  J Recept Res       Date:  1991

3.  Models of neurohypophyseal homeostasis.

Authors:  M D Fitzsimmons; M M Roberts; T G Sherman; A G Robinson
Journal:  Am J Physiol       Date:  1992-06

4.  Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?

Authors:  D de Wied; J Elands; G Kovács
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Spinal vasopressin modulates the reflex cardiovascular response to static contraction.

Authors:  C L Stebbins; A Ortiz-Acevedo; J M Hill
Journal:  J Appl Physiol (1985)       Date:  1992-02

6.  Vasopressin and noradrenaline coexistence in the rat locus ceruleus: differential decreases of their levels in distant brain areas after thermal and neurotoxic lesions.

Authors:  A R Caffé; F W van Leeuwen; R M Buijs; J van der Gugten
Journal:  Brain Res       Date:  1988-09-06       Impact factor: 3.252

7.  Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands.

Authors:  P A Phillips; J M Abrahams; J M Kelly; V Mooser; D Trinder; C I Johnston
Journal:  Endocrinology       Date:  1990-03       Impact factor: 4.736

8.  Motor disturbances and neurotoxicity induced by centrally administered somatostatin and vasopressin in conscious rats: interactive effects of two neuropeptides.

Authors:  C D Balaban; D A Fredericks; J N Wurpel; W B Severs
Journal:  Brain Res       Date:  1988-03-29       Impact factor: 3.252

9.  Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study.

Authors:  E Tribollet; M Goumaz; M Raggenbass; M Dubois-Dauphin; J J Dreifuss
Journal:  Brain Res Dev Brain Res       Date:  1991-01-15

10.  Arginine8-vasopressin potentiates the motor incoordinating effects of pentobarbital.

Authors:  A Marchese; S J Mihic; P H Wu; H Kalant
Journal:  Eur J Pharmacol       Date:  1991-09-24       Impact factor: 4.432

View more
  11 in total

Review 1.  Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.

Authors:  Danijela Markovic; R A John Challiss
Journal:  Cell Mol Life Sci       Date:  2009-07-23       Impact factor: 9.261

2.  In situ localization of vasotocin receptor gene transcripts in the brain-pituitary-gonadal axis of the catfish Heteropneustes fossilis: a morpho-functional study.

Authors:  Arpana Rawat; Radha Chaube; Keerrikkattil P Joy
Journal:  Fish Physiol Biochem       Date:  2018-12-03       Impact factor: 2.794

Review 3.  Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network.

Authors:  H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2014-08-04       Impact factor: 8.606

Review 4.  Developmental perspectives on oxytocin and vasopressin.

Authors:  Elizabeth A D Hammock
Journal:  Neuropsychopharmacology       Date:  2014-05-27       Impact factor: 7.853

5.  Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization.

Authors:  Sanja Milutinović-Smiljanić; Olivera Šarenac; Maja Lozić-Djurić; David Murphy; Nina Japundžić-Žigon
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 6.  Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.

Authors:  Zhimin Song; H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2017-10-18       Impact factor: 8.606

7.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

8.  Endogenous arginine vasopressin-positive retinal cells in arginine vasopressin-eGFP transgenic rats identified by immunohistochemistry and reverse transcriptase-polymerase chain reaction.

Authors:  Satoru Moritoh; Kaori Sato; Yasunobu Okada; Amane Koizumi
Journal:  Mol Vis       Date:  2011-12-15       Impact factor: 2.367

9.  Epstein-Barr Virus EBER Transcripts Affect miRNA-Mediated Regulation of Specific Targets and Are Processed to Small RNA Species.

Authors:  Julia Alles; Daniele Hasler; Syed Mohammad Ali Kazmi; Mathias Tesson; Andrew Hamilton; Linda Schlegel; Stefanie Marx; Norbert Eichner; Richard Reinhardt; Gunter Meister; Joanna B Wilson; Friedrich A Grässer
Journal:  Noncoding RNA       Date:  2015-09-30

Review 10.  Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.

Authors:  Nina Japundžić-Žigon; Maja Lozić; Olivera Šarenac; David Murphy
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.